Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine for Renal Protection From Contrast Induced Nephropathy in Diabetic ICU Patients
NCT07291375Phase 1Not yet recruiting
- Sponsor
- Minia University
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 1 trial of amlodipine in contrast-induced nephropathy (CIN) (2 arms), sponsored by Minia University. Primary endpoint: Serum Creatinine Level. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
amlodipine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT07291375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07291375.